The Gothenburg anorexia nervosa treatment study

The Gothenburg anorexia nervosa treatment study - a randomized control trial comparing individual cognitive behavioral therapy (I-CBT) and family therapy (FT) for young adults with anorexia nervosa

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN25181390

Enrollment

Registered

2015-07-21

Start date

2006-01-01

Completion date

Unknown

Last updated

2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anorexia nervosa Mental and Behavioural Disorders Anorexia nervosa

Interventions

Individual Cognitive Behavioral Therapy (I-CBT) aims to target specific factors related to the eating disorder psychopathology that are involved in the development and maintenance of the disorder. The

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Confirmed AN diagnosis 2. Accepting both treatment models 3. Age 17-25 4. Woman 5. Written consent

Exclusion criteria

Exclusion criteria: 1. If inpatient treatment is required 2. Serious personality disturbances 3. Serious suicidal risk 4. Drug dependence 5. Chaotic social situation 6. Present psychotherapeutic/psychopharmacological treatment

Design outcomes

Primary

Measure	Time frame
1. Body Mass Index (BMI) 2. The Rating of Anorexia and Bulimia Interview-revised version (RAB-R) is a Swedish semi-structured interview for clinical and research purposes for a wide range of eating disorder symptoms and related psychopathology through which the patient receives a DSM-IV diagnosis. All patients/parents were recruited consecutively and measured at baseline (after 2 weeks for treatment credibiltiy, Weaver), at 18 months and at 36 months after treatment start (baseline).	—

Measure

Time frame

1. Body Mass Index (BMI) 2. The Rating of Anorexia and Bulimia Interview-revised version (RAB-R) is a Swedish semi-structured interview for clinical and research purposes for a wide range of eating disorder symptoms and related psychopathology through which the patient receives a DSM-IV diagnosis. All patients/parents were recruited consecutively and measured at baseline (after 2 weeks for treatment credibiltiy, Weaver), at 18 months and at 36 months after treatment start (baseline).

—

Secondary

Measure	Time frame
1. Eating Disorder Inventory-3 (EDI-3) 2. Beck's depression Inventory (BDI) 3. Family Relation Scale (FARS) 4. Inventory of Interpersonal Problems (IIP) 5. Eating Disorder Expectations and Experiences (EDPEX) 6. Body Shape Questionnaire (BSQ) 7. Treatment Credibility 8. Visual Analoge Scale regarding Parental burden (VAS) 9. Rosenberg Self- Esteem Scale (RSE) 10. Treatment Satisfaction Scale (TSS) 11. Background questionnaire All patients/parents were recruited consecutively and measured at baseline (after 2 weeks for treatment credibiltiy, Weaver), at 18 months and at 36 months after treatment start (baseline).	—

Measure

Time frame

1. Eating Disorder Inventory-3 (EDI-3) 2. Beck's depression Inventory (BDI) 3. Family Relation Scale (FARS) 4. Inventory of Interpersonal Problems (IIP) 5. Eating Disorder Expectations and Experiences (EDPEX) 6. Body Shape Questionnaire (BSQ) 7. Treatment Credibility 8. Visual Analoge Scale regarding Parental burden (VAS) 9. Rosenberg Self- Esteem Scale (RSE) 10. Treatment Satisfaction Scale (TSS) 11. Background questionnaire All patients/parents were recruited consecutively and measured at baseline (after 2 weeks for treatment credibiltiy, Weaver), at 18 months and at 36 months after treatment start (baseline).

—

Countries

Sweden

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026